Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (421-430 of 441) with videos related to

Pageof 45
Sort By:
Journal of Medicinal Chemistry|November 24, 2015
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ ModulatorsRené Blöcher, Christina Lamers, Sandra K Wittmann, et al.
Circulation|May 17, 2012
Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarctionNorbert Degousee, Jeremy Simpson, Shafie Fazel, et al.
Journal of Medicinal Chemistry|October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-LipoxygenaseKerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Talanta|October 22, 2023
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care unitsSabine Kugler, Lisa Hahnefeld, Jan Andreas Kloka, et al.
Biochemical Pharmacology|June 26, 2025
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposingJanine Haupt, Oliver Keminer, Christina Neser, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Biomedicines|October 27, 2022
Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic ArthritisRobert Gurke, Annika Bendes, John Bowes, et al.
Antioxidants & Redox Signaling|July 13, 2017
Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene TherapyJessica Roos, Marcus Peters, Isabelle V Maucher, et al.
Pageof 45

Showing results (421-430 of 441) with videos related to

Sort By:
Pageof 45
Journal of Medicinal Chemistry|November 24, 2015
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ ModulatorsRené Blöcher, Christina Lamers, Sandra K Wittmann, et al.
Circulation|May 17, 2012
Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarctionNorbert Degousee, Jeremy Simpson, Shafie Fazel, et al.
Journal of Medicinal Chemistry|October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-LipoxygenaseKerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Talanta|October 22, 2023
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care unitsSabine Kugler, Lisa Hahnefeld, Jan Andreas Kloka, et al.
Biochemical Pharmacology|June 26, 2025
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposingJanine Haupt, Oliver Keminer, Christina Neser, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Biomedicines|October 27, 2022
Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic ArthritisRobert Gurke, Annika Bendes, John Bowes, et al.
Antioxidants & Redox Signaling|July 13, 2017
Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene TherapyJessica Roos, Marcus Peters, Isabelle V Maucher, et al.
Pageof 45